Events

From Bots to Agents: The Evolution of AI in Clinical Trials As AI technology evolves from simple bots to sophisticated agents, the potential for its application in clinical trials expands significantly. This summit will explore the journey of AI development and its implications for the clinical trials industry. Like last year, we are approaching speakers...

We will share a simplified example of a protocol outline, along with high-risk items that we want to reduce. How would you define KRIs to monitor the high-risk items? How would you determine the metric definition and thresholds? Will you get the same answers as our RBQM experts? Come along to take part – or...

Some companies have been early adopters of RBQM methodology and others have been laggards. What evidence is there of added value to the early adopters?

We will share an example of output that a central monitor might see and work together to investigate to determine if there is an issue and then try to determine the root causes. We will use the D-I-G-R root cause analysis method and show how it is more effective than the overly simplified “Five Whys.”...